Transpara
510(k) K192287
Transpara is a X-ray image interpretive software (FDA Class II; FDA product code QDQ) made by Screenpoint Medical B.V., cleared under FDA 510(k) K192287 on 10 Dec 2019 and listed in FDA GUDID since 12 Dec 2019 (UDI-DI 08719326450124), active as of 10 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing GUDID | Number08719326450124 | Date12 Dec 2019 | StatusListed |
| United States | FDA 510(k)SESE 510(k) | NumberK192287 | Date10 Dec 2019 | StatusActive |
Official records
- AccessGUDID record 08719326450124
- FDA 510(k) database K192287
From the FDA record
- Received by the FDA
- 22 Aug 2019
- FDA decision
- 10 Dec 2019 (Substantially Equivalent)
- FDA review time
- 110 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
FDA GUDID
- Device description
- The ScreenPoint Transpara system is intended for use as a concurrent reading aid for physicians interpreting screening mammograms from compatible FFDM systems, to identify regions suspicious for breast cancer and assess their likelihood of malignancy. Output of the device includes marks placed on suspicious soft tissue lesions and suspicious calcifications, region based scores, displayed upon the physicians query, indicating the likelihood that cancer is present in specific regions, and an overall score indicating the likelihood that cancer is present on the mammogram. Patient management decisions should not be made solely on the basis of analysis by Transpara.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K192287 decided 10 Dec 2019 Active
- FDA GUDID UDI-DI 08719326450124 listed 12 Dec 2019 Listed
Timeline
- Cleared FDA 510(k) K192287
- Listed FDA GUDID 08719326450124
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Generic name
- X-ray image interpretive software
- Model / reference
- 1.5.0 2D
- Primary DI / UDI-DI
- 08719326450124
- 510(k) Number
- FDA product code
- QDQ
- GMDN term
- X-ray image interpretive software
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2090
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Devices cleared under K192287
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Transpara 1.5.0 2D | 1.5.0 2D | 08719326450124 | — | On the market |
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Lunit Insight MMG (v1.1.10) by Lunit Inc.
- Genius AI Detection 2.0 by Hologic, Inc.
- See-Mode Augmented Reporting Tool by SEE-MODE TECHNOLOGIES PTY LTD
- Prostate MR AI (VA10A) by Siemens Healthcare GmbH
- ProFound AI Software V2.1 by Icad, Inc.
- ProFound Detection (V4.0) by Icad, Inc.
- ProstatID by SCANMED, LLC
- Lunit INSIGHT DBT (V1.2) by Lunit Inc.
- Saige-Dx by DEEPHEALTH
- BU-CAD by TaiHao Medical Inc.